The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS ...
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
As next-generation sequencing (NGS) workflows increasingly rely on lower DNA and RNA inputs and greater automation, minimising sample loss has become critical. Azenta Life Sciences offers a range ...
Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...
Clinical study on the assessment of first-line drug efficacy in advanced gastric cancer by monitoring circulating tumor cells through a self-developed microfluidic chip. Prognostic value of ...
A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...
A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results